Arrhythmia with Moviprep
Arrhythmia has been added as an adverse event with unknown frequency to the summary of product characteristics (SPC) for Moviprep (macrogol, sodium sulfate anhydrous, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate; Norgine). Additionally, the SPC now states that two litres of Moviprep can be taken in the morning of a clinical procedure.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069060
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com